Guangzhou Women's Health Cohort Study (GWHCS)

Breast Cancer Clinical Trial

Official title:

Guangzhou Women's Health Cohort Study (GWHCS)

Clinical Trial Details — Status: Suspended

Administrative data

• NCT number: NCT05506800
• Other study ID #: 2021048B00
• Status: Suspended
• Start date: March 3, 2016
• Est. completion date: August 21, 2026

Study information

• Verified date: February 2023
• Source: Guangzhou Women and Children's Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The Guangzhou Women's Health Cohort Study aims to explore the health trajectory and factors contributing to the health of women aged 35-64 in Guangzhou. Based on multiple population health registration data platforms, data of the cohort will provide information about the health of women across the lifespan, facilitating the decision-making process by local government . The cohort is progressing steadily, and the goal is to build a large women cohort covering 11 administrative districts of Guangzhou with a scale of 1 million by 2030.

Description:

The Guangzhou Women's Health Cohort Study aims to explore the health trajectory and factors contributing to the health of women aged 35-64 in Guangzhou. Based on multiple population health registration data platforms, data of the cohort will provide information about the health of women across the lifespan, facilitating the decision-making process by local government . The cohort is progressing steadily, and the goal is to build a large women cohort covering 11 administrative districts of Guangzhou with a scale of 1 million by 2030.

Recruitment information / eligibility

• Status: Suspended
• Enrollment: 1000000
• Est. completion date: August 21, 2026
• Est. primary completion date: July 21, 2026
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 35 Years to 64 Years

Eligibility

Inclusion Criteria:

• Women aged 35-64 years old

• Women with registered permanent residence in Guangzhou

• Women with informed consent

Exclusion Criteria:

• Women without informed consent

• Women with reading and/or writing difficulties

• Women with serious mental disorders

Related Conditions & MeSH terms

• Breast Cancer
• Cervical Cancer
• Colorectal Cancer
• Diabetes
• Endometrial Cancer
• Endometrial Neoplasms
• Hypertension
• Lung Cancer
• Ovarian Cancer
• Reproductive Disorder

Locations

Country	Name	City	State
China	Guangzhou Women and Children's Medical Center	Guangzhou	Guangdong

Sponsors (1)

Lead Sponsor	Collaborator
Guangzhou Women and Children's Medical Center

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Incidence and mortality rate of cancer	Data from cancer registration platforms	through study completion, an average of 2 years
Secondary	Hypertension and diabetes	Data from questionnaire	through study completion, an average of 2 years
Secondary	Reproductive health	Data from questionnaire	through study completion, an average of 2 years